CALLABLE MULTI DEFENDER VONTI - ROCHE GS/JOHNSON & JOHNSON/PFIZER INC/NOVARTIS N Stock

Certificat

RMA8HV

CH1293292327

Market Closed - Swiss Exchange 11:20:01 2024-05-08 EDT
97 USD +0.41% Intraday chart for CALLABLE MULTI DEFENDER VONTI - ROCHE GS/JOHNSON & JOHNSON/PFIZER INC/NOVARTIS N
Current month+4.75%
1 month+1.04%
Date Price Change Volume
24-05-08 97 +0.41% 0
24-05-07 96.6 +0.21% 0
24-05-06 96.4 +0.94% 0
24-05-03 95.5 +0.74% 0
24-05-02 94.8 +2.38% 0

Delayed Quote Swiss Exchange

Last update May 08, 2024 at 11:20 am

More quotes

Static data

Product typeObligations Convertibles
Buy / SellCALL
Underlying ROCHE HOLDING AG
IssuerLogo Issuer Vontobel Vontobel
RMA8HV
ISINCH1293292327
Date issued 2023-10-13
Strike 255 CHF
Maturity 2025-10-13 (522 Days)
Parity 0.26 : 1
Emission price 100 $
Emission volume N/A
Settlement les deux
Currency USD

Technical Indicators

Highest since issue 99.8 $
Lowest since issue 91.9 $
Spread 8 $
Spread %0.82%

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
222.3 CHF
Average target price
279.4 CHF
Spread / Average Target
+25.68%
Consensus
  1. Stock Market
  2. Certificates
  3. RMA8HV Certificat
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW